We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Increased Demand for Less Invasive Monitoring

By HospiMedica International staff writers
Posted on 04 Feb 2013
Low-end multiparameter patient monitors will show fastest revenue growth over the next five years, as a result of increased focus on monitoring the “unmonitored” and an increased demand for less invasive monitoring. More...
These are the latest findings of medical research group InMedica (Wellingborough, United Kingdom).

As the population eligible for public healthcare grows, increasing the strain on healthcare providers, demand for noninvasive monitoring has increased, following changes to healthcare provision in many countries. For example, in 2008, The US Centers for Medicare and Medicaid Services (CMS; Baltimore, MD, USA) stopped reimbursement for treatment of hospital-acquired complications, including vascular catheter-associated infection, deep vein thrombosis (DVT), and pulmonary embolism (PE) following certain orthopedic procedures.

With a growing elderly population requiring these procedures, and an increasing risk to healthcare providers that certain procedure complications will not be reimbursed, the US patient monitor device market is expected to show an increased demand for products that ensure susceptible patients are monitored throughout their stay, with adaptation to the patient’s condition. By providing continuity of care, hospitals can potentially reduce the time a patient is allocated a bed in a high-cost department, allowing them to be transferred to lower acuity wards much quicker than before.

“With restricted healthcare budgets, focus on cost inefficiencies has heightened. In response to a cut in reimbursement for hospital-acquired infections, healthcare providers are searching for solutions that reduce the risk of infection during treatment,” said Kelly Patrick, a senior analyst at InMedica. “Noninvasive patient monitoring devices provide fast and cost-efficient monitoring of patient vital signs. Furthermore, they improve the overall quality of care by reducing the pain caused during assessment. With a reduced risk of infection, plus reduced treatment and recovery times, demand for these devices is increasing.”

While it is still not clear if similar systems are likely to be adopted in other countries, the issue of increasing efficiency is being sought out by healthcare providers worldwide. As a result, Inmedica projects revenues for low-end multiparameter patient monitors will increase by over USD 250 million between 2011 and 2016.

Related Links:

InMedica
The US Centers for Medicare and Medicaid Services



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Pedicle Screw Platform
CREO DLX Stabilization System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.